Moreover, the latent upregulation of Cx3cl1 relative to Cx3cr1 and other proinflammatory genes provides support for the use of exogenous sCX3CL1 as an anti-microglia activation factor for the treatment of RP. Here, CX3CR1 is linked to retinitis pigmentosa 1.